X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28) 28
humans (23) 23
animals (22) 22
mice (18) 18
cancer (13) 13
cell line, tumor (10) 10
angiogenesis (9) 9
cell biology (9) 9
tumors (9) 9
article (8) 8
endothelial cells - metabolism (8) 8
female (8) 8
multidisciplinary sciences (8) 8
metastasis (7) 7
growth (6) 6
mice, inbred c57bl (6) 6
neovascularization, pathologic - metabolism (6) 6
research (6) 6
tumor microenvironment (6) 6
biological sciences (5) 5
blood vessels (5) 5
cell movement (5) 5
cell movement - physiology (5) 5
cells (5) 5
chemotherapy (5) 5
endothelial cells - cytology (5) 5
health aspects (5) 5
hela cells (5) 5
human umbilical vein endothelial cells (5) 5
neoplasms - blood supply (5) 5
oncology (5) 5
vascular endothelial growth factor a - metabolism (5) 5
anti-angiogenic therapy (4) 4
antiangiogenic therapy (4) 4
biopsy (4) 4
blood-vessels (4) 4
cell proliferation (4) 4
cell proliferation - drug effects (4) 4
endothelial growth-factor (4) 4
expression (4) 4
growth-factor (4) 4
hek293 cells (4) 4
neovascularization, pathologic - pathology (4) 4
physiological aspects (4) 4
survival (4) 4
vascular endothelial growth factor (4) 4
abridged index medicus (3) 3
analysis (3) 3
antineoplastic agents - pharmacology (3) 3
basement membrane - metabolism (3) 3
blood vessels - pathology (3) 3
brain tumors (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - pathology (3) 3
breast-cancer (3) 3
cancer cells (3) 3
care and treatment (3) 3
cell migration (3) 3
cells, cultured (3) 3
disease models, animal (3) 3
endothelial cell (3) 3
endothelial-cells (3) 3
engineering, biomedical (3) 3
extracellular-matrix (3) 3
genetic aspects (3) 3
genotype & phenotype (3) 3
glioblastoma - pathology (3) 3
hematology (3) 3
hypoxia (3) 3
in-vivo (3) 3
integrin (3) 3
integrin alpha6 - genetics (3) 3
mice, knockout (3) 3
mice, nude (3) 3
models (3) 3
models, biological (3) 3
neoplasms - metabolism (3) 3
neovascularization, pathologic - drug therapy (3) 3
neovascularization, physiologic - physiology (3) 3
phosphorylation (3) 3
prevention (3) 3
protein-serine-threonine kinases - metabolism (3) 3
rna interference (3) 3
vascular endothelial growth factor receptor-2 - metabolism (3) 3
vegf (3) 3
actin (2) 2
angiogenesis inhibitors - pharmacology (2) 2
animal models (2) 2
animal structures (2) 2
antibodies, monoclonal, humanized - pharmacology (2) 2
antibodies, neoplasm - pharmacology (2) 2
antigens, cd - genetics (2) 2
antigens, cd - metabolism (2) 2
basement-membrane (2) 2
benzylamines - pharmacology (2) 2
bevacizumab (2) 2
biochemical research methods (2) 2
blood vessels - metabolism (2) 2
brain (2) 2
brain neoplasms - drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4476 - 4481
Inhibition of the vascular endothelial growth factor (VEGF) pathway has failed to improve overall survival of patients with glioblastoma (GBM). We previously... 
Anti-angiogenic therapy | Macrophage polarization | Tumor microenvironment | Microglia reprogramming | Anti-tumor immunity | anti-angiogenic therapy | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | macrophage polarization | RANDOMIZED-TRIAL | ANGIOPOIETIN-2 | CANCER | THERAPY | microglia reprogramming | TIE2-EXPRESSING MONOCYTES | BLOOD-VESSELS | TUMOR-ASSOCIATED MACROPHAGES | tumor microenvironment | NORMALIZATION | anti-tumor immunity | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Antibodies, Bispecific - pharmacology | Vesicular Transport Proteins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neoplasms, Experimental - pathology | Xenograft Model Antitumor Assays | Macrophages - metabolism | Vesicular Transport Proteins - antagonists & inhibitors | Animals | Antibodies, Neoplasm - pharmacology | Ribonuclease, Pancreatic - metabolism | Glioblastoma - pathology | Cell Line, Tumor | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Mice | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Models | Macrophages | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Genotype & phenotype | Survival analysis | Protein expression | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4470 - 4475
Glioblastomas (GBMs) rapidly become refractory to anti-VEGF therapies. We previously demonstrated that ectopic overexpression of angiopoietin-2 (Ang-2)... 
Anti-angiogenic therapy | Colony-stimulating factor 1 | Tumor immunity | Tumor microenvironment | Macrophage | anti-angiogenic therapy | ANGIOPOIETIN-2 FUNCTIONS | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | macrophage | BEVACIZUMAB PLUS IRINOTECAN | RANDOMIZED-TRIAL | ANTIBODY | tumor immunity | KINASE INHIBITOR | ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | colony-stimulating factor 1 | tumor microenvironment | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neovascularization, Pathologic - pathology | Neoplasms, Experimental - pathology | Macrophages - metabolism | Animals | Antibodies, Neoplasm - pharmacology | Receptors, Vascular Endothelial Growth Factor - metabolism | Ribonuclease, Pancreatic - metabolism | Neovascularization, Pathologic - drug therapy | Glioblastoma - pathology | Cell Line, Tumor | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Glioblastoma - metabolism | Mice | Neovascularization, Pathologic - metabolism | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Quinazolines - pharmacology | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Drug Screening Assays, Antitumor | Survival analysis | Gene expression | Kinases | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2015, Volume 112, Issue 6, pp. 1827 - 1832
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2015, Volume 112, Issue 46, pp. 14325 - 14330
Journal Article
Nature Protocols, ISSN 1754-2189, 05/2018, Volume 13, Issue 5, pp. 1091 - 1105
Journal Article
Nature cell biology, ISSN 1465-7392, 10/2014, Volume 16, Issue 10, pp. 8 - 941
The mechanism by which angiogenic endothelial cells break the physical barrier of the vascular basement membrane and consequently sprout to form new vessels in... 
F-ACTIN | INVADOPODIA | TIP CELLS | INTEGRIN | BLOOD-VESSELS | EXTRACELLULAR-MATRIX | MICE | GROWTH-FACTOR | TRANSFORMED FIBROBLASTS | BASEMENT-MEMBRANE | CELL BIOLOGY | Neoplasms - metabolism | Cell Membrane Structures - physiology | Tetradecanoylphorbol Acetate - pharmacology | Humans | Lung Neoplasms - metabolism | Male | Melanoma, Experimental - metabolism | Green Fluorescent Proteins - genetics | Vascular Endothelial Growth Factor A - metabolism | Lung Neoplasms - physiopathology | Integrin alpha6beta1 - metabolism | Melanoma, Experimental - physiopathology | Cell Membrane Structures - metabolism | RNA Interference | HEK293 Cells | Integrin alpha6beta1 - genetics | Neovascularization, Pathologic - physiopathology | Neoplasms - physiopathology | Vascular Endothelial Growth Factor A - pharmacology | Endothelial Cells - physiology | Lung Neoplasms - blood supply | Green Fluorescent Proteins - metabolism | Cell Membrane Structures - drug effects | Melanoma, Experimental - blood supply | Endothelial Cells - metabolism | Mice, Inbred C57BL | Cells, Cultured | Neoplasms - blood supply | Matrix Metalloproteinase 14 - metabolism | Basement Membrane - metabolism | Mice, Knockout | Microscopy, Confocal | Animals | Cell Line, Tumor | Neovascularization, Pathologic - metabolism | HeLa Cells | Laminin - metabolism | Microscopy, Fluorescence | Endothelial Cells - drug effects | Blood vessels | Physiological aspects | Cell research | Neovascularization | Research | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2015, Volume 107, Issue 4, p. 1
Background: Matrix metalloproteinase (MMP) 14 may mediate tumor progression through vascular and immune-modulatory effects. Methods: Orthotopic murine breast... 
VASCULAR NORMALIZATION | INVASION | CANCER CELLS | ANGIOGENESIS | ONCOLOGY | MATRIX-METALLOPROTEINASE INHIBITORS | DRUG-DELIVERY | NITRIC-OXIDE SYNTHASE | TUMOR-GROWTH | EXPRESSION | BETA | Up-Regulation | Immunoglobulin G - blood | Breast Neoplasms - immunology | Humans | Gene Expression Regulation, Neoplastic | Neovascularization, Pathologic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Smad3 Protein - metabolism | Breast Neoplasms - metabolism | Nitric Oxide Synthase Type II - antagonists & inhibitors | Dose Fractionation | Female | Antineoplastic Agents - pharmacology | Matrix Metalloproteinase 14 - drug effects | Antibodies, Monoclonal - pharmacology | Enzyme Inhibitors - pharmacology | Smad2 Protein - metabolism | Nitric Oxide Synthase Type II - drug effects | Breast Neoplasms - blood supply | Matrix Metalloproteinase 14 - metabolism | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Macrophages - enzymology | Gene Expression Regulation, Enzymologic | Breast Neoplasms - radiotherapy | Phenotype | Animals | Signal Transduction - drug effects | Mammary Neoplasms, Experimental | Cell Line, Tumor | Macrophages - drug effects | Amidines - pharmacology | Mice | Benzylamines - pharmacology | Transforming Growth Factor beta - metabolism | Nitric Oxide Synthase Type II - metabolism | Enzymes | Genotype & phenotype | Immunoglobulins | Immunology | Radiation therapy | Gene expression | Tumors | Index Medicus
Journal Article
Neoplasia, ISSN 1476-5586, 2012, Volume 14, Issue 8, pp. 719 - IN19
Journal Article